Not applicableStudy completedNCT06485674
What this trial is testing
Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus
Who this might be right for
Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus
AstraZeneca 561